- £1.90bn
- £3.32bn
- £275.00m
- 58
- 26
- 68
- 47
2019 September 30th | R2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 229 | 222 | 258 | 287 | 275 |
Cost of Revenue | |||||
Gross Profit | 141 | 150 | 153 | 163 | 164 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 66.5 | 85 | 67 | -45.5 | 215 |
Operating Profit | 162 | 137 | 191 | 332 | 59.6 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 131 | 99.1 | 152 | 299 | 27.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | 115 | 82.8 | 110 | 229 | 25.6 |
Net Income Before Extraordinary Items | |||||
Net Income | 115 | 82.8 | 110 | 229 | 25.6 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 115 | 82.8 | 110 | 229 | 25.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.203 | 0.128 | 0.161 | 0.307 | 0.036 |
Dividends per Share |